Find trials
Search tips

A Study Of Crohn's Disease Patient Symptoms During Ingestion Of Oral Contrast For CT Or MR Enterography And Morphologic

Overview

About this study

The purpose of this study is observe the symptoms in Crohn’s patients undergoing CTE and MRE using a short survey before, during, and after the patient’s administration of each oral contrast bottle and correlate the symptoms in each phase with the patient Crohn’s imaging findings in the scan clinical report.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Above 18 years old

  • Scheduled for CT or MR Enterography

  • Established diagnosis of Crohn’s disease

  • Agrees and consents to fill the symptoms surveys

 

Exclusion Criteria: 

  • Patients who do not speak English

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 

Eligibility last updated 05/09/2025. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

David Bruining, M.D.

Open for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20597187

Mayo Clinic Footer